KRRO · Korro Bio Inc
United States · RS rating 88 · As of 2026-11-03
| Price | 15.86 USD |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 88 / 98 / 94 / 16 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 41 / 53 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +36.7% |
| Sales growth Q/Q | +18.5% |
| Distance from 52-week high | +56.9% |
| Market cap (USD) | $196.1M |